Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
25024388
DOI
10.4049/jimmunol.1302974
PII: jimmunol.1302974
Knihovny.cz E-zdroje
- MeSH
- adaptorové proteiny vezikulární transportní imunologie MeSH
- adenylátcyklasový toxin imunologie MeSH
- antigeny CD11b imunologie MeSH
- antigeny CD80 biosyntéza MeSH
- antigeny CD86 biosyntéza MeSH
- Bordetella pertussis imunologie MeSH
- buněčná diferenciace imunologie MeSH
- cytotoxické T-lymfocyty imunologie MeSH
- dendritické buňky cytologie imunologie MeSH
- interferon beta imunologie MeSH
- interleukin-1beta biosyntéza MeSH
- interleukin-6 biosyntéza MeSH
- kultivované buňky MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- myši MeSH
- receptor interferonu alfa-beta genetika MeSH
- receptory interleukinu-1 imunologie MeSH
- signální transdukce imunologie MeSH
- TNF-alfa biosyntéza MeSH
- toll-like receptor 4 imunologie MeSH
- tyrosin genetika MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- adaptorové proteiny vezikulární transportní MeSH
- adenylátcyklasový toxin MeSH
- antigeny CD11b MeSH
- antigeny CD80 MeSH
- antigeny CD86 MeSH
- Cd86 protein, mouse MeSH Prohlížeč
- interferon beta MeSH
- interleukin-1beta MeSH
- interleukin-6 MeSH
- receptor interferonu alfa-beta MeSH
- receptory interleukinu-1 MeSH
- TICAM-1 protein, mouse MeSH Prohlížeč
- Tlr4 protein, mouse MeSH Prohlížeč
- TNF-alfa MeSH
- toll-like receptor 4 MeSH
- tyrosin MeSH
Deciphering the mechanisms that allow the induction of strong immune responses is crucial to developing efficient vaccines against infectious diseases and cancer. Based on the discovery that the adenylate cyclase from Bordetella pertussis binds to the CD11b/CD18 integrin, we developed a highly efficient detoxified adenylate cyclase-based vector (CyaA) capable of delivering a large variety of Ags to the APC. This vector allows the induction of protective and therapeutic immunity against viral and tumoral challenges as well as against transplanted tumors in the absence of any added adjuvant. Two therapeutic vaccine candidates against human papilloma viruses and melanoma have been developed recently, based on the CyaA vector, and are currently in clinical trials. We took advantage of one of these highly purified vaccines, produced under good manufacturing practice-like conditions, to decipher the mechanisms by which CyaA induces immune responses. In this study, we demonstrate that CyaA binds both human and mouse CD11b(+) dendritic cells (DCs) and induces their maturation, as shown by the upregulation of costimulatory and MHC molecules and the production of proinflammatory cytokines. Importantly, we show that DCs sense CyaA through the TLR4/Toll/IL-1R domain-containing adapter-inducing IFN-β pathway, independent of the presence of LPS. These findings show that CyaA possesses the intrinsic ability to not only target DCs but also to activate them, leading to the induction of strong immune responses. Overall, this study demonstrates that Ag delivery to CD11b(+) DCs in association with TLR4/Toll/IL-1R domain-containing adapter-inducing IFN-β activation is an efficient strategy to promote strong specific CD8(+) T cell responses.
Citace poskytuje Crossref.org
Pore-formation by adenylate cyclase toxoid activates dendritic cells to prime CD8+ and CD4+ T cells